|
positive regulation of I-kappaB phosphorylation
|
GO_1903721 |
[Any process that activates or increases the frequency, rate or extent of I-kappaB phosphorylation.] |
|
Fas signaling pathway
|
GO_0036337 |
[The series of molecular signals initiated by the binding of a ligand to a Fas receptor on the surface of the cell, and ending with the regulation of a downstream cellular process, e.g. transcription. Fas is a death domain-containing member of the tumor necrosis factor receptor (TNFR) superfamily.] |
|
positive regulation of centriole elongation
|
GO_1903724 |
[Any process that activates or increases the frequency, rate or extent of centriole elongation.] |
|
dendritic cell migration
|
GO_0036336 |
[The movement of a dendritic cell within or between different tissues and organs of the body.] |
|
negative regulation of centriole elongation
|
GO_1903723 |
[Any process that stops, prevents or reduces the frequency, rate or extent of centriole elongation.] |
|
luteal cell differentiation
|
GO_1903728 |
[The process in which a relatively unspecialized cell acquires the specialized features of a luteal cell. Large luteal cells develop from granulosa cells. Small luteal cells develop from theca cells.] |
|
avascular cornea development in camera-type eye
|
GO_0036331 |
[The progression of an avascular cornea over time, from its formation to the mature structure. Corneal avascularity (the absence of blood vessels in the cornea) is required for optical clarity and optimal vision. Avascular corneas are present in most animals, except Manatees.] |
|
cornea development in camera-type eye
|
GO_0061303 |
[The progression of the cornea over time, from its formation to the mature structure. The cornea is the transparent structure that covers the anterior of the eye.] |
|
GO_0036330
|
GO_0036330 |
|
|
lysine biosynthetic process via alpha-aminoadipate and N2-acetyl-alpha-aminoadipate
|
GO_0051976 |
[The chemical reactions and pathways resulting in the formation of lysine via the intermediates alpha-aminoadipic acid and N2-acetyl-alpha-aminoadipate. This pathway of prokaryotic lysine biosynthesis via alpha-aminoadipate was discovered in the hyper-thermophilic Gram-negative eubacterium Thermus thermophilus. The pathway proceeds as follows: alpha-ketoglutarate is converted to homocitrate, which is metabolized to 3-carboxyhex-2-enedioate and then homoisocitrate. This is then decarboxylated to form alpha-ketoadipate, which is then converted to alpha-aminoadipate. This undergoes acetylation, to form N2-acetyl-alpha-aminoadipate, and is then phosphorylated to give N2-acetyl-alpha-aminoadipyl-delta-phosphate. This is converted to N2-acetyl-alpha-aminoadipate semialdehyde, which is then converted to N2-acetyl-L-lysine. A final deacetylation reaction produces L-lysine.] |
|
lysine biosynthetic process via alpha-aminoadipate and saccharopine
|
GO_0051975 |
[The chemical reactions and pathways resulting in the formation of lysine via the intermediates alpha-aminoadipic acid and saccharopine. This pathway is used by yeast and fungi to synthesize the essential amino acid L-lysine, and pathway intermediates are often incorporated into secondary metabolic processes. The pathway proceeds as follows: alpha-ketoglutarate is converted to homocitrate, which is metabolized to 3-carboxyhex-2-enedioate and then homoisocitrate. This is then decarboxylated to form alpha-ketoadipate, which is then converted to alpha-aminoadipate. This is then reduced to form alpha-aminoadipate 6-semialdehyde, which is metabolized to saccharopine and finally L-lysine.] |
|
lysophospholipid:sodium symporter activity
|
GO_0051978 |
[Enables the directed movement of lysophospholipids from one side of a membrane to the other. A lysophospholipid is a phospholipid that lacks one of its fatty acyl chains; it is an intermediate formed during digestion of dietary and biliary phospholipids.] |
|
obsolete regulation of telomerase activity
|
GO_0051972 |
[OBSOLETE. Any process that modulates the frequency, rate or extent of telomerase activity, the catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1). Telomerases catalyze extension of the 3'- end of a DNA strand by one deoxynucleotide at a time using an internal RNA template that encodes the telomeric repeat sequence.] |
|
obsolete negative regulation of telomerase activity
|
GO_0051974 |
[OBSOLETE. Any process that stops or reduces the activity of the enzyme telomerase, which catalyzes of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1).] |
|
obsolete positive regulation of telomerase activity
|
GO_0051973 |
[OBSOLETE. Any process that activates or increases the frequency, rate or extent of telomerase activity, the catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1).] |
|
alginic acid acetylation
|
GO_0051979 |
[The addition of O-acetyl ester groups to alginic acid, a linear polymer of D-mannuronate and L-guluronate.] |
|
vascular endothelial growth factor receptor-2 signaling pathway
|
GO_0036324 |
[The series of molecular signals initiated by a ligand binding to a vascular endothelial growth factor receptor-2 (VEGFR-2) on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.] |
|
smooth muscle cell-matrix adhesion
|
GO_0061302 |
[The binding of a smooth muscle cell to the extracellular matrix via adhesion molecules.] |
|
vascular endothelial growth factor receptor-1 signaling pathway
|
GO_0036323 |
[The series of molecular signals initiated by a ligand binding to a vascular endothelial growth factor receptor-1 (VEGFR-1) on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.] |
|
cerebellum vasculature morphogenesis
|
GO_0061301 |
[The process in which the vasculature of the cerebellum is generated and organized.] |